0001179929-22-000016.txt : 20220103 0001179929-22-000016.hdr.sgml : 20220103 20220103193127 ACCESSION NUMBER: 0001179929-22-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lockhart Stephen H CENTRAL INDEX KEY: 0001856013 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31719 FILM NUMBER: 22503533 MAIL ADDRESS: STREET 1: C/O NATIONAL RESEARCH CORPORATION STREET 2: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOLINA HEALTHCARE, INC. CENTRAL INDEX KEY: 0001179929 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 134204626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 BUSINESS PHONE: 5624353666 MAIL ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 FORMER COMPANY: FORMER CONFORMED NAME: MOLINA HEALTHCARE INC DATE OF NAME CHANGE: 20020812 4 1 wf-form4_164125627416608.xml FORM 4 X0306 4 2022-01-01 0 0001179929 MOLINA HEALTHCARE, INC. MOH 0001856013 Lockhart Stephen H 2180 HARVARD STREEET, SUITE 400 SACRAMENTO CA 95815 1 0 0 0 Common Stock 2022-01-01 4 A 0 173 318.08 A 719 D Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. Represents the closing price of the Issuer's common stock on December 31, 2021. Jeff D. Barlow, by power of attorney for Stephen H. Lockhart. 2022-01-03 EX-24 2 limitedpowerofattorney-loc.htm LIMITED POWER OF ATTORNEY



LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS

Know all by these presents, that the undersigned hereby constitutes and
appoints Jeff D. Barlow and Codruta Boggs, and each acting singly, the
undersigned's true and lawful attorney-in-fact to:

1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or stockholder of Molina Healthcare,
Inc. (the "Company"), Forms 3, 4, and 5 and amendments thereto in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder; and

2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Form 3, 4, or 5 or amendment thereto and timely file such form with the
United States Securities and Exchange Commission (the "SEC") and any
stock exchange or similar authority.

The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
Power of Attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned's holdings of and transaction in securities of the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.  This Power of Attorney may
be filed with the SEC as a confirming statement of the authority granted
herein.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 6th day of May 2021.


/s/ Stephen H. Lockhart, MD
Signature

Stephen H. Lockhart, MD
Printed Name

Exhibit 24